CD4 and diabetes mellitus: The observation that IL‐10 production is acquired by vaccine‐specific CD4+ and CD8+ T cells with a variety of cytokine profiles and is not restricted to a specific T helper or Tc subpopulation suggests that, in diabetes, vaccination generates a generalized anti‐inflammatory response, potentially reducing the efficacy of the vaccine.